Stem Cell Agency Selects Investment Banker as Chair
The California Institute for Regenerative Medicine's governing board has tapped Jonathan Thomas as its next chair. Thomas, who replaces outgoing board Chair Robert Klein, is a former Wall Street investment banker who co-founded Saybrook Capital, an investment and private-equity company that has secured funding for clinical trials involving embryonic stem cells.
- "Stem Cell Agency Names New Chairman to Six-Figure Post" (Van Oot, "Capitol Alert," Sacramento Bee, 6/23).